Infant Bacterial Therapeutics AB

Infant Bacterial Therapeutics AB

  • Price (EUR)16.70
  • Today's Change0.16 / 0.97%
  • Shares traded0.00
  • 1 Year change11.33%
  • Beta--
Data delayed at least 15 minutes, as of Oct 22 2019.
More ▼


    Key statistics

    On Tuesday, Infant Bacterial Therapeutics AB (9IB:STU) closed at 16.70, 51.82% above the 52 week low of 11.00 set on Nov 23, 2018.
    52-week range
    11.00Nov 23 201824.45Jul 17 2019
    Markit short selling activity
    Previous close16.54
    Average volume0.00
    Shares outstanding10.85m
    Free float9.05m
    P/E (TTM)--
    Market cap2.00bn SEK
    EPS (TTM)-3.60
    Data delayed at least 15 minutes, as of Oct 22 2019.
    More ▼
    The Financial and Risk business of Thomson Reuters is now Refinitiv
    All markets data located on FT.com is subject to the FT Terms & Conditions
    All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
    Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
    Markit Short Selling Activity © Markit. All rights reserved.
    Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.